(AND) Andlauer Healthcare Gr - Ratings and Ratios
Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA0342231077
AND EPS (Earnings per Share)
AND Revenue
AND: Logistics, Transportation, Warehousing, Packaging, Distribution, Delivery
Andlauer Healthcare Group Inc. is a leading supply chain management company that offers customized third-party logistics (3PL) and specialized transportation solutions to the healthcare sector in Canada and the United States. With a strong presence in the industry, the company operates through two key segments: Specialized Transportation and Healthcare Logistics, providing a comprehensive range of services including logistics and distribution, packaging, temperature-controlled services, air freight forwarding, and ground transportation.
The companys platform is designed to serve healthcare manufacturers, wholesalers, distributors, 3PL providers, and others, offering technology-enabled supply chain solutions for a diverse range of products, including pharmaceuticals, vaccines, biologics, and medical devices. With a history dating back to 1991, Andlauer Healthcare Group Inc. has established itself as a trusted partner in the healthcare industry, with its headquarters located in Vaughan, Canada.
From a technical analysis perspective, the stock has shown a strong upward trend, with its current price of 52.89 CAD being close to its 52-week high of 53.68 CAD. The short-term moving averages (SMA20 and SMA50) indicate a potential bullish crossover, suggesting a continued upward momentum. The Average True Range (ATR) of 0.29 CAD indicates a relatively low volatility, making it an attractive option for investors seeking stability.
Fundamentally, Andlauer Healthcare Group Inc. has a market capitalization of 2078.48M CAD, with a price-to-earnings (P/E) ratio of 30.51 and a forward P/E ratio of 29.24, indicating a relatively stable valuation. The companys return on equity (RoE) of 16.58% suggests a strong profitability. Considering the companys strong industry position, diversified services, and stable financials, we forecast a potential price target of 60 CAD in the next 12-18 months, driven by the growing demand for healthcare logistics and supply chain management services.
Our forecast is based on the analysis of the companys technical and fundamental data, indicating a strong potential for growth. With the stock currently trading near its 52-week high, we expect a continued upward momentum, driven by the companys strong industry position and stable financials. As the healthcare industry continues to evolve, Andlauer Healthcare Group Inc. is well-positioned to capitalize on the growing demand for logistics and supply chain management services, making it an attractive investment opportunity.
Additional Sources for AND Stock
AND Stock Overview
| Market Cap in USD | 1,494m |
| Sector | Industrials |
| Industry | Integrated Freight & Logistics |
| GiC Sub-Industry | Air Freight & Logistics |
| IPO / Inception |
AND Stock Ratings
| Growth Rating | 30.4 |
| Fundamental | 53.6 |
| Dividend Rating | 62.0 |
| Rel. Strength | 27.6 |
| Analysts | - |
| Fair Price Momentum | 51.61 CAD |
| Fair Price DCF | 119.61 CAD |
AND Dividends
| Dividend Yield 12m | 0.98% |
| Yield on Cost 5y | 1.36% |
| Annual Growth 5y | 14.76% |
| Payout Consistency | 98.3% |
| Payout Ratio | 28.8% |
AND Growth Ratios
| Growth Correlation 3m | 29.6% |
| Growth Correlation 12m | 67.1% |
| Growth Correlation 5y | 14.4% |
| CAGR 5y | 6.79% |
| CAGR/Max DD 5y | 0.21 |
| Sharpe Ratio 12m | -0.12 |
| Alpha | 31.57 |
| Beta | 0.061 |
| Volatility | 19.46% |
| Current Volume | 120.4k |
| Average Volume 20d | 120.1k |
As of July 01, 2025, the stock is trading at CAD 52.61 with a total of 120,436 shares traded.
Over the past week, the price has changed by +2.11%, over one month by -1.29%, over three months by +35.21% and over the past year by +36.42%.
Partly, yes. Based on ValueRay´s Fundamental Analyses, Andlauer Healthcare Gr (TO:AND) is currently (July 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 53.57 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of AND is around 51.61 CAD . This means that AND is currently overvalued and has a potential downside of -1.9%.
Andlauer Healthcare Gr has no consensus analysts rating.
According to our own proprietary Forecast Model, AND Andlauer Healthcare Gr will be worth about 55.7 in July 2026. The stock is currently trading at 52.61. This means that the stock has a potential upside of +5.95%.
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 54.8 | 4.2% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 55.7 | 5.9% |